COVID hiccup has SA medtech sector at crossroads

South Australia’s fledgling medical device industry is at a crossroads, as the state’s medtech startups ride a surge of technological improvements amid an increasingly competitive global landscape.

Bionomics in $20 million capital raise ahead of PTSD trial

The share price for SA-based mental health treatment startup Bionomics has doubled in the past month, as the company looks to raise $20 million in capital ahead of its upcoming PTSD drug trial.

The Bionomics headquarters in Thebarton, Adelaide. Image: supplied.

Bionomics in $16 million capital raise to progress PTSD trial

Adelaide-based drug, research and development group Bionomics is raising $16 million in capital from North American and European investors ahead of its latest PTSD drug trial in mid-2021.